During the past decade, Hye Jin Yoo conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hye Jin Yoo" are "Atherosclerosis" (4 trials) and "Obesity" (1 trials). Many other conditions were trialed in "Hye Jin Yoo" in a lesser frequency.

Most popular intervention types in "Hye Jin Yoo" are "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Cross section study" (2 trials) and "Cross sectional study" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hye Jin Yoo" are 3 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hye Jin Yoo". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hye Jin Yoo, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hye Jin Yoo, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".